Abstract:GGC repeat expansion in the 5' untranslated region (UTR) of NOTCH2NLC is associated with a broad spectrum of neurological disorders, especially neuronal intranuclear inclusion disease (NIID). Studies have found that GGC repeat expansion in NOTCH2NLC induces the formation of polyglycine (polyG)-containing protein, which is involved in the formation of neuronal intranuclear inclusions. However, the mechanism of neurotoxicity induced by NOTCH2NLC GGC repeats is unclear. Here, we used NIID patient-specific induced pluripotent stem cell (iPSC)-derived 3D cerebral organoids (3DCOs) and cellular models to investigate the pathophysiological mechanisms of NOTCH2NLC GGC repeat expansion. IPSC-derived 3DCOs and cellular models showed the deposition of polyG-containing intranuclear inclusions. The NOTCH2NLC GGC repeats could induce the upregulation of autophagic flux, enhance integrated stress response and activate EIF2α phosphorylation. Bulk RNA sequencing for iPSC-derived neurons and single-cell RNA sequencing (scRNA-seq) for iPSC-derived 3DCOs revealed that NOTCH2NLC GGC repeats may be associated with dysfunctions in ribosome biogenesis and translation. Moreover, NOTCH2NLC GGC repeats could induce the NPM1 nucleoplasm translocation, increase nucleolar stress, impair ribosome biogenesis and induce ribosomal RNA sequestration, suggesting dysfunction of membraneless organelles in the NIID cellular model. Dysfunctions in ribosome biogenesis and phosphorylated EIF2α and the resulting increase in the formation of G3BP1-positive stress granules may together lead to whole-cell translational inhibition, which may eventually cause cell death. Interestingly, scRNA-seq revealed that NOTCH2NLC GGC repeats may be associated with a significantly decreased proportion of immature neurons while 3DCOs were developing. Together, our results underscore the value of patient-specific iPSC-derived 3DCOs in investigating the mechanisms of polyG diseases, especially those caused by repeats in human-specific genes.

Phase-separated stress granules and processing bodies are compromised in Myotonic Dystrophy Type 1

Condensation properties of stress granules and processing bodies are compromised in myotonic dystrophy type 1

Treatment of Type 1 Myotonic Dystrophy by Engineering Site-specific RNA Endonucleases that Target (CUG)n Repeats

CUG repeat RNA-dependent proteasomal degradation of MBNL1 in a cellular model of myotonic dystrophy type 1

The Rna-Binding Protein Cugbp1 Regulates Stability of Tumor Necrosis Factor Mrna in Muscle Cells - Implications for Myotonic Dystrophy

DM1 Transgenic Mice Exhibit Abnormal Neurotransmitter Homeostasis and Synaptic Plasticity in Association with RNA Foci and Mis-Splicing in the Hippocampus

Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1

Small Molecule Screening Identifies HSP90 as a Modifier of RNA Foci in Myotonic Dystrophy Type 1

CCG interruptions are unstable and hypermethylated in DM1 patients

Myotonic Dystrophy: Evidence for a Possible Dominant-Negative RNA Mutation

Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1

rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences

Identification of ZNF850 as a novel CTG repeat expansion-related gene in myotonic dystrophy type 1 patient-derived iPSCs

RNA mis-splicing in children with myotonic dystrophy is associated with physical function

Destabilization of neuromuscular junctions and deregulation of activity-dependent signalling pathways in Myotonic Dystrophy type I

Dosage effect of multiple genes accounts for multisystem disorder of myotonic dystrophy type 1.

Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing

HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.

GGC Repeat Expansion in NOTCH2NLC Induces Dysfunction in Ribosome Biogenesis and Translation.

RNA mis‐splicing in children with congenital myotonic dystrophy is associated with physical function

Cellular Senescence and Aging in Myotonic Dystrophy